One study reported that 34% of sensory neuropathy patients had pathogenic biallelic RFC1 expansions of which 42% exhibited sensory neuropathy only.14 Our results confirm the importance of screening for RFC1 expansions with a similar prevalence among neuropathy-only patients as among those manifesting ataxia without neuropathy. This evidence concerns the gene RFC1 and sensory peripheral neuropathy.